US EditionBariatric Surgery for Weight Loss Shows Greater Long-Term Benefits than GLP-1 Medicines
4 Articles
4 Articles
Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.
People with type 2 obesity and diabetes who pass by surgery for weight loss (such as bariarthritis) live more and face less serious health problems compared to those treated only with agonist drugs of the GLP-1 receptor (like osempic), revealed a study of Cleveland Clinic. In order to get married after 50: why more couples wish to recommend in adults Insonia: Advise approved an independent treatment in the brain, chosen best by Oxford University…
Scienmag: Latest Science and Health News
BIOENGINEER.ORGCleveland Clinic Study Finds Bariatric Surgery Offers Superior Long-Term
In a groundbreaking new study published in Nature Medicine, researchers from Cleveland Clinic have revealed compelling evidence that metabolic surgery significantly improves long-term health outcomes for individuals living with obesity and type 2 diabetes compared to treatment with GLP-1 receptor agonist medications alone. This large-scale observational study underscores the profound and enduring benefits of bariatric surgery, emphasizing its ro…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
